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Abstract
Background Algae are becoming an increasingly important component of land plant metabolic engineer-
ing projects. Land plants and algae have similar enough genetics to allow relatively straight-
forward gene transfer and they also share enough metabolic similarities that algal enzymes
often function in a plant cell environment. Understanding metabolic systems in algae can
provide insights into homologous systems in land plants. As examples, algal models are
currently being used by several groups to better understand starch and lipid metabolism
and catabolism, ﬁelds which have relevance in land plants. Importantly, land plants and
algae also have enough metabolic divergence that algal genes can often provide new meta-
bolic traits to plants. Furthermore, many algal genomes have now been sequenced, with
many more in progress, and this easy access to genome-wide information has revealed
that algal genomes are often relatively simple when compared with plants.
Scope One example of the importance of algal, and in particular microalgal, resources to land
plant research is the metabolic engineering of long-chain polyunsaturated fatty acids
into oilseed crops which typically uses microalgal genes to extend existing natural plant
biosynthetic pathways. This review describes both recent progress and remaining
challenges in this ﬁeld.
Long-chain vs. short-chain
polyunsaturated fatty acids
Long-chain polyunsaturated fatty acids (LC-PUFA) have a
carbon backbone of at least 20 carbons in length and
contain multiple double-bond desaturations. Long-chain
polyunsaturated fatty acids can be grouped into either
an omega-3 (v3) or v6 category based on the position
of the ﬁrst double bond from the methyl, or v, fatty
acid terminus. Fatty acid nomenclature can be used to
succinctly refer to fatty acids and, as an example,
18:4
D6,9,12,15 refers to the short-chain stearidonic acid
which contains only 18 carbons and four double bonds,
or desaturations, at the 6, 9, 12 and 15 carbon positions
from the carboxyl, or D, terminus (Fig. 1). Long-chain
polyunsaturated fatty acids have critical roles in human
health and development, with studies indicating that
deﬁciencies in these fatty acids can increase the risk or
severity of cardiovascular disease (von Schacky 2006),
inﬂammatory diseases and rheumatoid arthritis
(Kremer et al. 1995; Simopoulos 2002; Nagel et al.
2003), hypertension (Ueshima et al. 2007) and
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tia (Freeman et al. 2006; Parker et al. 2006; Schaefer
et al. 2006). Recently, the human fatty acid receptor
GPR120 was characterized as being an v3-speciﬁc
receptor with strong anti-inﬂammatory and insulin-
sensitizing effects (Oh et al. 2010). Humans have
limited ability to synthesize LC-PUFA, with infants in par-
ticular requiring the majority of these fatty acids through
the diet. This is particularly the case with the v3 LC-PUFA
eicosapentaenoic acid (EPA), docosapentaenoic acid
(DPA) and docosahexaenoic acid (DHA) and the v6
LC-PUFA arachidonic acid (ARA), with studies indicating
positive effects on infant cognitive development after
ARA and DHA supplementation (Birch et al. 2000). As a
result many infant formulae now contain LC-PUFA,
although it is worth noting that ARA supplementation
for adults is, in many cases, often considered to be
of lesser value since the v6 LC-PUFA tend to be
pro-inﬂammatory in nature and counteract the strong
anti-inﬂammatory effects of v3 LC-PUFA.
Just as there are differences in physiological effect
between v3 and v6 LC-PUFA (i.e. anti- vs.
pro-inﬂammatory, respectively), it is important to note
that there are signiﬁcant differences arising from
intake of long-chain vs. short-chain (SC) v3 PUFA. Alpha-
linolenic acid (ALA) is a common v3 SC-PUFA found in
seed oils of ﬂax/linseed, canola/rapeseed, soybean and
walnut. Stearidonic acid (SDA), another v3 SC-PUFA, is
less common in plant oils, with the predominant
natural plant dietary sources being echium and borage.
Human studies along with livestock and aquafeeding
trials have demonstrated that SDA in particular can be
converted, in part, to the LC-PUFA EPA and, to a lesser
extent, DPA (James et al. 2003; Tocher et al. 2006;
Harris et al. 2008). Thus, although the direct health
beneﬁts of v3 SC-PUFA are relatively limited when com-
pared with LC-PUFA, they are viewed by some as a surro-
gate for dietary EPA supplementation (Whelan 2009)
due to this in vivo conversion and transgenic SDA crops
are under development.
It is clear, however, that direct intake of v3 LC-PUFA
results in the greatest health beneﬁts (James et al.
2003; Burdge and Calder 2005; Wang et al. 2006). Fur-
thermore, the conversion of v3 SC-PUFA including SDA
to DHA has not been observed in either humans or aqua-
culture species to any signiﬁcant degree (James et al.
2003; Tocher et al. 2006; Harris et al. 2008).
Docosahexaenoic acid ﬁlls speciﬁc physiological (e.g.
Mori et al. 1999) and structural roles (such as a neural
and retinal component) that cannot be replaced by
EPA or other LC-PUFA, and ensuring adequate dietary
intake of DHA is therefore required. Consumer awareness
of the health beneﬁts of v3 LC-PUFA is growing (due in
part to the efforts of organizations such as the
Omega-3 Centre (www.omega-3centre.com) and GOED
(www.goedomega3.com)), and there is an increasing
demand for these fatty acids which will be difﬁcult for
current sources to meet in a sustainable manner.
Current and future sources of v3 LC-PUFA
The main source of v3 LC-PUFA is wild-harvest marine
ﬁsh stocks and these, unfortunately, are widely recog-
nized to be in decline. One widely cited paper describes
the amount of large predatory ﬁsh in the oceans as
being at only 10 % of pre-industrial times (Myers and
Worm 2003), although this ﬁgure has been disputed.
One of the authors claimed in a later publication that
Fig. 1 v3 long-chain (≥C20) polyunsaturated fatty acids and their predominant natural sources. *Some Boraginaceae such as Echium
plantagineum contain SDA, although this species is not generally recognized as an oilseed crop species.
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stocks was such that ‘all commercial ﬁsh and seafood
may collapse’ by 2048 (Worm et al. 2006). This view is
hardly unanimous either (see Ho ¨lker et al. (2007),
Wilberg and Miller (2007) and Jaenike (2007) for
comment), but efforts are now under way to rebuild ﬁsh-
eries and to improve their sustainability. Regardless, ﬁsh-
eries alone are unlikely to meet the growing demand for
v3 LC-PUFA and alternative sources of these fatty acids
must be found. Aquaculture cannot meet the demand
since ﬁsh themselves do not produce LC-PUFA but, like
humans, accumulate LC-PUFA through their diet. In
fact, the aquaculture industry itself contributes enor-
mously to demand for LC-PUFA, with  90 % of global
ﬁsh oil production being used in aquafeeds. Logically,
the major producers of v3 LC-PUFA, microalgae, would
be a good target for increased production and, indeed,
commercial microalgal sources of v3 LC-PUFA are avail-
able. Microbial production tends to supply relatively
niche applications such as infant formulae and nutra-
ceuticals due to high production costs and is unlikely
to scale up adequately for large-volume applications.
Oilseed crops, with their production capacity and rela-
tively low cost, would be an excellent and sustainable
source of v3 LC-PUFA. For example, several calculations
have recently been performed to examine global consu-
mer needs for these oils and using a daily 500 mg
requirement, as is recommended by national health
bodies, a global population reaching 8 billion by 2025,
and assuming ﬁsh contain 0.2–3.5 g of v3 LC-PUFA per
100 g of oil, it was estimated that the current global
ﬁsh harvest (93 Mt per annum) will fall well short of
this requirement. On the other hand,  2.5 million hec-
tares of an oilseed crop (about 2 % of total world
acreage under cultivation to major oilseed crops) con-
taining 10–15 % DHA and EPA in its oil could replace
all the ﬁsh oil currently being used globally. Oilseed
crop plants do not naturally synthesize these fatty
acids, meaning that a metabolic engineering solution
would be required before this potential source could
become a reality. An oilseed crop with v3 LC-PUFA pro-
duction capability would provide an excellent alternative
to high-volume, environmentally sensitive marine-based
oils. Such an oil could be used in many applications: (i) as
an ingredient for aquaculture feeds to provide aquacul-
ture species with v3 LC-PUFA both for their own develop-
mental requirements and to meet consumer demands
for v3 LC-PUFA content in ﬁsh; (ii) as an animal feed to
produce v3 LC-PUFA-enriched meat, eggs and milk; (iii)
as a food (e.g. bread or milk) supplement in an
oxidation-protected form; (iv) directly, as a nutraceutical
supplement similar to the way in which ﬁsh oil capsules
are currently used. As an additional beneﬁt, an oilseed
source would be vegetarian and thus satisfy a require-
ment for an important sector of the global market.
v3 LC-PUFA biosynthesis
Biosynthesis of LC-PUFA occurs by either aerobic or
anaerobic pathways in nature, with the latter found pre-
dominantly in some marine bacteria (e.g. Vibrio and
Shewanella) and protists (e.g. Schizochytrium and
Thraustochytrium). Anaerobic synthesis of LC-PUFA is
performed by polyketide synthase (PKS) pathways
which are cyclical in nature, with multi-enzyme com-
plexes iteratively performing a series of desaturations
and 2-carbon elongations using malonyl-CoA and
acetyl-CoA as the source of the carbon units. The
complex nature of the PKS pathway and the requirement
for associate genes has to date resulted in this being a
challenging pathway to introduce into plants. The
aerobic pathway, on the other hand, consists of a
series of distinct desaturation and elongation steps
with the genes coding for each of the enzymes having
been isolated and characterized. This review focuses
on metabolic engineering of plants by the aerobic
pathway, although it is worth noting that considerable
progress has been made in understanding and engineer-
ing the PKS pathways (Metz et al. 2001, 2006, 2009;
Lippmeier et al. 2009).
Aerobic production of LC-PUFA (Fig. 2) can be thought,
in the context of plant metabolic engineering, to com-
mence with the native plant fatty acid oleic acid. This
fatty acid is ﬁrst D12-desaturated to produce linolenic
acid (LA), which is in turn v3-desaturated to produce
ALA. Linolenic acid and ALA are the respective substrates
for the v6 and v3 LC-PUFA pathways, with the ﬁrst com-
mitted step in both pathways being a D6-desaturation to
produce either g-linoleic acid (GLA) (v6) or SDA (v3). All
the fatty acids up to this point can be found naturally in
angiosperms, although GLA and SDA are relatively rare
and efforts have been made to engineer these
SC-PUFA into oilseed species (see below). The C18 fatty
acids GLA and SDA are then D6-elongated to the long-
chain (≥C20) fatty acids di-homo-g-linoleic acid (DGLA)
and eicosatetraenoic acid (ETA), respectively. This
elongation (and the others described in this review) con-
sists of four consecutive enzymatic steps (condensation,
ketoreduction, dehydration and enoyl reduction),
although the transgenic introduction of the condensing
enzyme or ‘elongase’ is sufﬁcient to confer speciﬁcity
to the entire elongation with the other elongation reac-
tion components being supplied by the host organism.
The products of the D6-elongation, DGLA and ETA, are
then D5-desaturated to ARA and EPA, respectively.
Arachidonic acid marks the end of the traditionally
AoB PLANTS 2011 plr011 doi:10.1093/aobpla/plr011, available online at www.aobplants.oxfordjournals.org & The Authors 2011 3
Petrie and Singh — Engineering lower plant pathways into higher plantsrepresented v6 LC-PUFA pathway, although ARA can be
D5-elongated to docosatetraenoic acid which can ﬁnally
be D4-desaturated to DPAv6. Similarly, EPA can be
D5-elongated to DPA (DPAv3) which is then
D4-desaturated to produce DHA. This ‘D6’ pathway is
the most commonly found aerobic pathway, although
the alternative ‘D8’ pathway also exists. In this
pathway, LA and ALA are D9-elongated to eicosadienoic
acid (EDA) and eicosatrienoic acid (ETRA), respectively,
which are then D8-desaturated to DGLA and ETA
(Fig. 2). At this point, the D6 and D8 pathways merge
and subsequent desaturations and elongations continue
as described above.
Long-chain polyunsaturated fatty acid
metabolic engineering
It is surprising to some people that ﬁsh and other marine
species, the predominant source of v3 LC-PUFA oils in
the human diet, are not the source of the genes used
in LC-PUFA metabolic engineering applications. Rather,
the genes come from microalgae (that ﬁsh and other
marine species consume), fungi and protists. As
already mentioned, genes coding for each step in the
LC-PUFA pathways have been isolated and character-
ized, and several groups have been expressing these in
land plants to modify the fatty acid proﬁles of the
plant oil (Fig. 3, Table 1). There are several technical or
scientiﬁc challenges that must be met before oilseed
crops can be engineered to accumulate adequate
levels of LC-PUFA. These challenges are mainly focused
on increasing the conversion of the native plant fatty
acid substrates through to the LC-PUFA of interest with
as few intermediate fatty acids as possible. In theory,
this simply requires the use of transgenic enzymes
which have high conversion efﬁciencies. In practice,
Fig. 3 Some notable LC-PUFA engineering results discussed in this review. See Table 1 for details of genes used in these studies. Format
adapted from Venegas-Calero ´n et al. (2010).
Fig. 2 Long-chain polyunsaturated fatty acid biosynthesis
pathways in lower plants, including algae (v6 and v3),
marine bacteria and protists (PKS). Enzymes are referred to
as either ‘E’ for elongase (e.g. D9E is D9-elongase) or ‘D’ for
desaturase (e.g. D6D is D6-desaturase) and belong to the
aerobic pathway for LC-PUFA synthesis. A generalized
scheme for the processive synthesis of LC-PUFA by the anaero-
bic PKS pathway is also shown. In this system acetyl-CoA
undergoes several rounds of sequential reactions (keto-
synthase, keto-reductase, dehydratase and enoyl reductase)
that result in repeated elongations by two carbons per cycle
of a fatty acyl chain esteriﬁed to an acyl carrier protein.
Names and abbreviations for the v3 fatty acids are provided
in Fig. 1 and v6 fatty acids are 18:2
D9,12, LA; 18:3
D6,9,12,
GLA; 20:3
D8,11,14, DGLA; 20:4
D5,8,11,14, ARA. The D9-elongated
fatty acids are 20:2
D11,14, EDA and 20:3
D11,14,17, ETRA.
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Table 1 The genes used in the studies described in Fig. 3. *Denotes an algal gene source.
Publication Pathway Host species Genes
Qi et al. (2004) D9 Arabidopsis thaliana leaf Isochrysis galbana D9-elongase*
Euglena gracilis D8-desaturase*
Mortierella alpina D5-desaturase
Abbadi et al. (2004) D6 Linum usitatissimum seed Phaeodactylum tricornutum D6-desaturase*
Physcomitrella patens D6-elongase
Phaeodactylum tricornutum D5-desaturase*
Robert et al. (2005) D6 Arabidopsis thaliana seed Danio rerio D5/6-desaturase
Caenorhabditis elegans D6-elongase
Pavlova salina D5-elongase*
Pavlova salina D4-desaturase*
Kinney et al. (2004) D6 Glycine max seed Arabidopsis thaliana D15-desaturase
Saprolegnia diclina D17-desaturase
Mortierella alpina D6-desaturase
Mortierella alpina D6-elongase
Mortierella alpina D5-desaturase
Kinney et al. (2004) D6 Glycine max somatic embryo As above plus:
Pavlova sp. D5-elongase*
Schizochytrium D4-desaturase*
Wu et al. (2005) D6 Brassica juncea seed Calendula ofﬁcinalis D12-desatuase
Phytophthora infestans v3-desaturase
Thraustochytrium sp. LPCAT*
Pythium irregulare D6-desaturase
Thraustochytrium sp. C18 elongase*
Thraustochytrium sp. D5-desaturase*
Oncorhynchus mykiss C18/C20 elongase
Thraustochytrium sp. D4-desaturase*
Cheng et al. (2010) D6 Brassica carinata seed Pythium irregulare D6-desaturase
Thraustochytrium sp. C18 elongase*
Thraustochytrium sp. D5-desaturase*
Calendula ofﬁcinalis D12-desatuase
Phytophthora infestans v3-desaturase
Petrie et al. (2010a) D6 Arabidopsis thaliana seed Micromonas pusilla D6-desaturase*
Pyramimonas cordata D6-elongase*
Pavlova salina D5-desaturase*
Pyramimonas cordata D5-elongase*
Pavlova salina D4-desaturase*
Petrie et al. (2010b) D9 Nicotiana benthamiana leaf Pavlova salina:
D9-elongase*
D8-desaturase*
D5-desaturase*
D5-elongase*
D4-desaturase*
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enzymes are not only affected by actual enzyme activity
but also by factors such as substrate dichotomy, the
requirement of some enzymes to use substrates from
certain metabolic pools.
The biosynthesis of v3 LC-PUFA in land plants was ﬁrst
reported in 2004 with publications describing the intro-
duction of both the D8 and D6 pathways. Qi et al.
(2004) demonstrated the production of 3 % EPA and
6.6 % ARA in Arabidopsis thaliana leaf tissue by a D8
pathway consisting of the Isochrysis galbana
D9-elongase, Euglena gracilis D8-desaturase and
Mortierella alpina D5-desaturase with constitutive 35S
promoters. This study demonstrated that production of
LC-PUFA in land plants was possible, albeit in leaf
tissue. Shortly after, Abbadi et al. (2004) published the
production of LC-PUFA in the seeds of tobacco and
linseed by the D6 pathway. In this pathway, SDA
(11.4 %) and GLA (16.8 %) were produced in linseed,
although these fatty acids were not effectively
D6-elongated with only 0.8 % EPA and 1.0 % ARA
being produced. These studies were important proofs
of concept that the production of v3 LC-PUFA in land
plants was possible.
v6 vs. v3 biosynthesis
These two 2004 publications also showed the compli-
cation of parallel v6 and v3 pathways in which an indi-
vidual gene generally functions in both branches (Fig. 2).
Using the D6 pathway as an example, the D6-desaturase
is the ﬁrst committed step of both v6 and v3 LC-PUFA
production and can desaturate both LA and ALA. The
D6-desaturation of LA to produce GLA, however, effec-
tively reduces the production of ALA since LA is also
the substrate for D15-desaturase activity, which pro-
duces ALA. One seemingly obvious solution is to increase
the production of ALA by introducing more efﬁcient
D15-desaturase activity, but the success of this
approach can be limited by the fact that competition
for LA remains between the D15- and D6-desaturases.
This can be overcome by introducing a more broadly
functioning v3-desaturase that not only converts LA to
ALA by D15-desaturation but can also convert the v6
fatty acids GLA, DGLA and ARA to their v3 counterparts.
Another approach is to reduce or remove the compe-
tition for LA experienced by the D15-desaturase by
using a D6-desaturase that favours ALA as a substrate.
A patent describing LC-PUFA synthesis in soybean
somatic embryos (Kinney et al. 2004) contained an
example of the ﬁrst approach of including an
v3-desaturase gene that could convert v6 products to
their v3 counterparts. In this work, a D6 pathway
coupled to a strong D17-desaturase resulted in the
production of nearly 20 % EPA with very little ARA
accumulation due to the v3-desaturase activity of the
D17-desaturase. Wu et al. (2005) also included a
D17-desaturase in their D6 pathway and this, combined
with a lysophosphatidyl acyltransferase (LPAT) which
was included as a way of increasing incorporation of
novel fatty acids, resulted in the accumulation of up to
15 % EPA in Brassica juncea seeds. Similar results were
obtained by Cheng et al. (2010) who engineered Brassica
carinata with a D6 pathway including an v3-desaturase
and accumulated in excess of 20 % EPA in seed.
The alternative method of reducing v6 products,
namely to use a D6-desaturase with preference for the
v3 substrate ALA, has also been demonstrated. Several
examples have been reported of genes encoding such
D6-desaturases (Sayanova et al. 2003; Garcı ´a-Maroto
et al. 2006; Hoffmann et al. 2008; Petrie et al. 2010a),
although the strength of the preference varies. For
example, the primula D6-desaturase isolated by Saya-
nova et al. (2003) essentially has v3 speciﬁcity with
high activity on ALA but very low v6 activity (Ruiz-Lo ´pez
et al. 2009). The v3 preference observed by Hoffmann
et al. (2008) and Petrie et al. (2010a) in their
D6-desaturases was not as strong as that seen in the
primula enzyme, although the D6-desaturases were
from microalgal sources and seemingly able to access
acyl-CoA substrate pools, as will be discussed below.
Other microalgal acyl-CoA desaturases such as the
Ostreococcus tauri D6-desaturase (Domergue et al.
2005) did not have v3 preference.
Several D9-elongases have now been isolated (Qi et al.
2002; Damude et al. 2008), although none has a strong
v3 preference. Use of these genes in high-level v3
LC-PUFA production would therefore likely require the
addition of an v3-desaturase. This is exempliﬁed by
the isolation and transgenic plant expression of the
entire D8 DHA pathway from a single algal species,
Pavlova salina (Petrie et al. 2010b). In this study, a high
proportion of the newly produced LC-PUFA were v6
despite these being almost absent in the native algal
fatty acid proﬁle, in which large amounts of v3
LC-PUFA are present (Zhou et al. 2007). Since the
P. salina D9-elongase did not have v3 preference, it is
likely that this alga either has a strong v3-desaturase
or a method of selectively accumulating v3 LC-PUFA.
Acyl-CoA pathways
Alternative approaches to building v3 LC-PUFA pathways
have been taken with several groups focusing on the
construction of acyl-CoA pathways to reduce the ‘pool
shufﬂing’ that can occur in transgenic LC-PUFA path-
ways. The LC-PUFA elongation condensing reactions
occur using acyl-CoA thioester substrates (the ‘acyl-CoA
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lated are lipid-linked desaturases that generally use a
phosphatidylcholine substrate (the ‘acyl-PC pool’).
A desaturated fatty acid must therefore be transferred
between the acyl-PC and acyl-CoA pools by acyltransfer-
ase enzymes before a subsequent elongation can occur.
The synthesis and accumulation of triacylglycerol in
seeds are likely more complex than previously thought
(Bates et al. 2009) and the requirement for acyltransfer
between pathway steps presents opportunities for the
novel fatty acid to be lost into pools which are, relatively,
metabolically inert. This leads to a build-up of intermedi-
ate fatty acids along the biosynthetic pathway, with the
eventual result being that the terminal product (e.g.
DHA) does not accumulate to adequate levels. One sol-
ution to this challenge is the addition of acyltransferase
enzymes which are capable of rapidly converting the
newly elongated or newly desaturated fatty acids to
the appropriate pool (e.g. the approach taken by Wu
et al. (2005) described above in which an LPAT was
included in the pathway). Unfortunately, this approach
requires the addition of at least one extra gene to an
already sizeable transgenic pathway. Fortunately, an
alternative solution exists in the form of acyl-CoA
desaturases.
The majority of desaturases are lipid linked, although
there are published examples of enzymes which are
able to function on acyl-CoA thioesters (Kajikawa et al.
2004; Domergue et al. 2005; Hoffmann et al. 2008;
Petrie et al. 2010a) and several of these have been
used in DHA pathways. Using such acyl-CoA desaturases
means that elongation and desaturation can occur in
the same metabolic pool, and thus avoid the efﬁciency
and accumulation losses associated with the ‘pool shuf-
ﬂing’ described above. Acyl-CoA LC-PUFA pathways can
often be characterized by high elongation efﬁciency.
Petrie et al. (2010a), for instance, described a large
increase in D6-elongation efﬁciency when the
D6-elongase substrate, SDA, was produced by an
acyl-CoA D6-desaturase when compared with SDA pro-
duced by an acyl-PC D6-desaturase. Similarly, Hoffmann
et al. (2008) were able to construct an acyl-CoA pathway
with efﬁcient elongation, although the amounts of
LC-PUFA produced were very low.
Improving D5-elongation
A ﬁnal area of recent focus has been the D5-elongation
step. Although Wu et al. (2005) and Cheng et al. (2010)
demonstrated signiﬁcant levels of EPA production (15
and 25 %, respectively), there have, to date, been no
reports of high levels of DHA production in transgenic
plants. This is mostly due to low D5-elongation efﬁciency
and it has been suggested that the inclusion of enzymes
with suitable acyl-transfer function (such as the acyl-
transferases described above) may be required to
achieve adequate efﬁciency. Indeed, the authors of
this review have previously had similar difﬁculty in
obtaining adequate D5-elongation efﬁciency (Robert
et al. 2005), although the recent isolation of a highly efﬁ-
cient enzyme from the microalga Pyramimonas cordata
is encouraging (Petrie et al. 2009). This enzyme functions
extremely well in plants (Fig. 3) and may be an impor-
tant component of a transgenic DHA biosynthesis
pathway for oilseed crops. Figure 3 demonstrates the
importance of careful enzyme selection when construct-
ing transgenic pathways, with a clear increase in EPA
elongation observed with the P. cordata D5-elongase.
Furthermore, Fig. 3 also demonstrates the effectiveness
of using a D6-desaturase with v3 preference (i.e. extre-
mely low v6 fatty acid levels without using an
v3-desaturase) and an acyl-CoA-like nature (i.e. the sub-
sequent D6-elongation is extremely efﬁcient). The high
conversion efﬁciency of the P. salina D5-desaturase
used in this pathway, both in terms of desaturation
and provision of the D5-desaturated products to the
D5-elongase, indicates that this enzyme may also be
able to access acyl-CoA substrates although this is not
yet biochemically proven. If so, this demonstrates the
importance of using a pathway in which most of the
desaturases are acyl-CoA-dependent for DHA synthesis.
It is also worth noting that all transgenes in this
pathway are from algal sources.
Long-chain polyunsaturated fatty acid
production and accumulation in oilseed
crops
Figure 4 describes results from a rapid transient
expression system in a model plant, Nicotiana
benthamiana (Wood et al. 2009; Petrie et al. 2010c).
This transient expression of a DHA pathway alongside
the A. thaliana DGAT1 yielded an impressive level of
EPA and DHA accumulation in the leaf triglycerides.
Such an oil composition, if replicated in oilseeds,
would yield oils whose fatty acid proﬁle will compare
very favourably to that of a ﬁsh. Other groups rely
extensively on A. thaliana, cultured soybean embryos
or similar, relatively rapid, systems to test hypotheses
and constructs before transforming crop species. The
transition from an interesting result in a model
system to a good result in an oilseed crop species is
not necessarily trivial. Whilst this transition is broadly
applicable to most crop metabolic engineering pro-
jects, the introduction of LC-PUFA to crops presents
some speciﬁc problems. LC-PUFA, including DHA, are
unusual fatty acids in a land plant context and may
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oilseed crop species. The physiological impact of this
would likely vary, depending on both the amount of
oil present and available in the seed during germina-
tion and the proportion of LC-PUFA accumulated in
the seed oil. High-oil species such as rapeseed or ﬂax-
seed naturally have a greater energy store than lower
oil crops which can then be accessed during germina-
tion since these species have been selectively bred to
produce oil in excess of germination requirements.
The effective removal of a fraction of these ‘surplus’
triacylglycerols would likely have a relatively small
effect on germination and seedling vigour when com-
pared with lower oil crop species such as soybean.
Similarly, it could reasonably be expected that the pro-
duction of high levels of LC-PUFA in lower oil crop
species could dramatically affect germination rates
and seedling vigour.
It will also be interesting to observe the positional dis-
tribution of LC-PUFA in the triacylglycerols constituting
high LC-PUFA crop oil, especially since studies have indi-
cated that LC-PUFA located on the sn-2 position are
more stable under storage and also more bioavailable
to human infants, and possibly adults, than those on
the sn-1,3 positions (Berry 2009).
Acceptance of crop-based v3 LC-PUFA
As with many projects in the broader ﬁeld of land plant
metabolic engineering, the scientiﬁc and technical
hurdles around the production of LC-PUFA are only part
of the challenge. The real-world delivery of a crop-based
source of v3 LC-PUFA will inevitably require acceptance
of the technology by the broader public. A genetically
modiﬁed v3 LC-PUFA crop will have tremendous environ-
mental sustainability credentials due to the role it will
play in relieving pressure on global ﬁsh stocks. Further-
more, such a crop will have direct health beneﬁts for
the consumers and, given the increasing awareness
of the importance of v3 LC-PUFA in the general public,
these factors are likely to play an important part in
increasing consumer acceptance.
Some regions have a high level of aversion to
transgenic technologies due to perceived risks
Fig. 4 Docosahexaenoic acid production in plant leaf. Gas chromatography (GC) traces of fatty acid methyl esters (FAME) produced from
triacylglycerol in N. benthamiana leaf tissue transiently expressing single-gene Cauliﬂower mosaic virus 35S promoter-driven binary con-
structs containing the P19 gene silencing suppressor, Micromonas pusilla D6-desaturase, P. cordata D6-elongase, P. salina D5-desaturase,
P. cordata D5-elongase (A) or P. salina D5-elongase (B), and the P. salina D4-desaturase. The accumulation of EPA in the sample using the
P. salina D5-elongase demonstrates the manner in which metabolic pathways can be tailored by careful selection of a single gene in the
pathway.
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2004;C o xet al. 2008a, b), although this does not
appear to be the case in other countries. One study,
for example, has found that 99 % of consumers in the
USA were more concerned with hygiene, sanitation and
food-borne illnesses than with biotechnology (IFIC
2005). Regardless, it is useful to review consumers’ atti-
tudes to transgenic v3 LC-PUFA in particular: Cox et al.
(2008a, b, 2011) have investigated both US and Austra-
lian consumer attitudes toward v3 LC-PUFA and also
v3 LC-PUFA produced from transgenic oilseeds. They
found that whilst a minority had concerns about the
use of transgenic technology, the majority of study par-
ticipants, generally, were either ambivalent or positive
about the use of transgenic v3 LC-PUFA oilseeds. This
agrees with earlier data which also suggested that con-
sumers are likely to accept transgenic technology where
there is a direct beneﬁt to the consumer (Hossain et al.
2003; Hossain and Onyango 2004). Interestingly, consu-
mers tended to prefer a transgenic v3 LC-PUFA oilseed
as the preferred source of oil to be incorporated into
bread, milk and supplements above oils sourced from
ﬁsh and algae (Cox et al. 2011).
Conclusions and forward look
Algal genes have contributed signiﬁcantly to the
LC-PUFA metabolic engineering efforts described in this
short review. Similarly, research towards the in planta
production of carotenoids, and in particular astaxanthin,
continues to require the use of genes from algal species
that naturally synthesize these compounds (see Misawa
(2009) for a review). In a broader context, algal model
species such as Chlamydomonas reinhardtii are now
being used to better understand metabolism and cata-
bolism in plants and plant-like species (Wijffels and
Barbosa 2010). Recent focus on ﬁnding or engineering
sustainable sources of biofuels has seen increased use
of algal models to investigate mechanisms of lipid
accumulation and starch conversion. Wang et al.
(2009) and Moellering and Benning (2010) have
described the formation of lipid droplets in
C. reinhardtii after nitrogen starvation, with Miller et al.
(2010) then describing changes in transcript abundance
in these systems. It is likely that ﬁndings such as these
will have relevance in land plants due to the high
degree of similarity between the organisms (Hicks
et al. 2001). There has been considerable effort under
way by the US Department of Energy-funded Joint
Genome Institute to sequence the genomes of a
number of algal species. This data set is publically avail-
able at http://genome.jgi-psf.org/. Detailed analyses of
algal genomes not only provide important information
for research into functional genomics, but also increase
our understanding of the physiology, environmental
adaptation mechanisms, morphogenesis and evolution
of organisms (especially the origin of photosynthetic
organisms) and their evolution into land plants.
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